U.S. House · 119th Congress · H.R. 8857
Next GEN Act of 2026
To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Joseph D. MorelleD-NY-25
- Introduced
- May 15, 2026, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (4)
2 Democrats, 2 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Josh GottheimerD-NJ-5
- Thomas H. Kean, Jr.R-NJ-7
- August PflugerR-TX-11
Signed on later
- Donald G. DavisD-NC-1August 27, 2026